← All Sponsors
SPONSOR

Sichuan University

Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Epilepsy (treatment Refractory)Pancreatic CancerAdjuvant Therapy
NCT06863350
Recruiting

Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial）

Epilepsy (treatment Refractory)
China View Trial →
NCT06344156 Phase 1
Recruiting

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

Pancreatic Cancer
China View Trial →